Series C - Viome

Series C - Viome

Investment Firm

Overview

Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.

Announced Date

Aug 18, 2023

Closed on Date

Aug 18, 2023

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Khosla Ventures

Khosla Ventures

Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Bold Capital Partners

Bold Capital Partners

Bold Capital Partners is a convertible_note and early_stage_venture and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorEastward Capital Partners
Participant InvestorWR Hambrecht
Participant InvestorBold Capital Partners
Participant InvestorKhosla Ventures

Round Details and Background

Viome raised $86500000 on 2023-08-18 in Series C

Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 15, 2022
Series C - Viome
6-67.0M
Aug 18, 2023
Series C - Viome
5-86.5M
Jan 01, 2022
Debt Financing - Viome
1-20.0M
Jul 31, 2017
Series A - Viome
2-15.0M

Recent Activity

There is no recent news or activity for this profile.